Home・Lista de Ações・Certara Inc

Certara Inc

Fechado

SetorSaúde

8.07 -1.22

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

7.99

Máximo

8.18

Indicadores-chave
By Trading Economics
Rendimento	-2.9M -8.8M
Vendas	3.3M 107M
P/E Médio do Setor	100.714 68.51
EPS	0.09
Margem de lucro	-8.196
Funcionários	1,515
EBITDA	-16M 16M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+1.73% upside

Dividendos
By Acuity
Próximos Ganhos	5 de nov. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	474M 1.3B
Abertura anterior	9.29
Fecho anterior	8.07

Sentimento de Notícias

By Acuity

50%

128 / 340 Ranking em Healthcare

Certara Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

7 de ago. de 2026, 19:26 UTC

Certara Inc shares are higher today, maintaining a positive trajectory since Thursday. The stock remains above its 20-day moving average.

6 de ago. de 2026, 20:02 UTC

News

Certara Inc is rising today, driven by strength in the Health Care Technology sub-sector. The stock remains above its 20-day moving average.

5 de ago. de 2026, 20:13 UTC

Certara Inc shares are lower in after-market trading amid broader market fluctuations and rising gold prices, reflecting ongoing geopolitical tensions.

4 de ago. de 2026, 20:03 UTC

News

Certara reported a second-quarter net loss of $6.1 million and lowered its full-year guidance, contributing to a decline in shares during today's session.

3 de ago. de 2026, 19:26 UTC

News

Certara Inc shares are higher, supported by gains in the Health Care Technology sector. The company will report Q2 2026 results on August 4.

31 de jul. de 2026, 19:26 UTC

Certara Inc shares are higher today, recovering from an early dip and trading near the top of their one-month range. No specific news was identified.

30 de jul. de 2026, 19:58 UTC

Certara Inc is lower amid Health Care Technology sub-sector weakness. The stock reversed an early gain and remains above its 20-day moving average.

29 de jul. de 2026, 18:53 UTC

Health Care Technology sector strength is lifting Certara Inc during Wednesday's session. The asset remains above its 20-day moving average, marking six straight days of gains.

28 de jul. de 2026, 18:36 UTC

Certara Inc is higher during Tuesday's session, continuing gains from Monday. The stock remains above its 20-day moving average despite an intraday pullback.

27 de jul. de 2026, 19:07 UTC

Certara Inc shares are trading higher during Monday's session, reflecting positive momentum since Friday's close, despite no specific company news identified.

24 de jul. de 2026, 18:02 UTC

Certara Inc shares are trading higher today, continuing gains since Thursday's close. No specific news was identified to explain the upward movement.

23 de jul. de 2026, 20:06 UTC

Shares of Certara Inc are higher during Thursday's session, continuing a notable increase since Wednesday's close. No specific news was identified for this movement.

22 de jul. de 2026, 20:04 UTC

Certara Inc's shares are higher during Wednesday's session, recovering from an early decline amid broader market uncertainty ahead of the Federal Reserve meeting.

20 de jul. de 2026, 19:31 UTC

News

Certara Inc partners with NVIDIA to enhance its AI biosimulation platform. Shares are higher, reflecting positive market sentiment around the collaboration.

Comparação entre Pares

Variação de preço

Certara Inc Previsão

Preço-alvo

By TipRanks

1.73% parte superior

Previsão para 12 meses

Média 8.21 USD 1.73%

Máximo 9 USD

Mínimo 7 USD

Com base em 9 analistas de Wall Street que oferecem metas de preço de 12 meses para Certara Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

9 ratings

Comprar

Manter

Vender

Com base em 9 analistas que deram avaliações de ações para Certara Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

128 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.